Abstract:Background Rheumatoid arthritis (RA) is a chronic progressive disease characterised by synovial inflammation, autoantibody production, cartilage and bone destruction. Bone erosions are a key feature of RA reflecting both disease severity and disease progression. An imbalance between Th17 and regulatory T cells (Treg cells) has been extensively recognised in both patients and model animals of RA. Oral administration of berberine, an isoquinoline alkaloid, has been showed to ameliorate various symptoms of autoimmune diseases including RA. Objectives To verify whether berberine may prevent bone erosions during RA progression and to explore the potential mechanisms in Collagen-induced arthritis (CIA) rat model. Methods The severity of arthritis was expressed as mean arthritic index on a 0–4 scale according to the following criteria: 0=no oedema or swelling; 1=slight oedema and erythema limited to the foot and/or ankle; 2=slight oedema and erythema from the ankle to the tarsal bone; 3=moderate oedema and erythema from the ankle to the tarsal bone; and 4=severe oedema and erythema from the ankle to the entire leg. Each limb was graded, and thus the maximum possible score was 16 for each animal. The threshold score of rats with established CIA is 2. The CIA rats were divided into 3 groups: placebo group (n=4), low dose berberine group (50 mg/kg/day, n=4) and high dose berberine group (200 mg/kg/day, n=4). Placebo and berberine were intragastrically administered to all rats for 4 and 8 weeks after the CIA models were established. TNF-α, IL-1β, IL-6, IL-17A, and IgG in the serum were measured by ELISA kits (purchased from Abcam). The hind paws of rats were scanned by micro CT (Scanco, Switzerland). Results The thickness of the swollen hind paws was reduced in the high dose berberine group (200 mg/kg/day) compared with the placebo group (Fig A). No significant differences were observed in the levels of TNF-α, IL-1β, and IL-6 between the three groups. However, the levels of IL-17A and IgG were significantly decreased in the high dose berberine group when compared with the placebo group (Fig A). Micro CT data revealed that berberine could significantly improve the microstructure of CIA rats including the bone volume ratio (BV/TV), areal bone mineral density (aBMD) and trabecular separation (Tb Sp) (Fig B and C). Development of bone erosion had also been partially prevented. Figure 1 A; B microstructure; C 3D reconstruction Conclusions Berberine attenuated the symptoms of CIA rats and may prevent bone erosion progression by suppressing IL-17A in CIA. Human studies are required to confirm whether it may serve as a potential treatment for RA in the future. Disclosure of Interest None declared

Berberine ameliorates collagen-induced arthritis in mice by restoring macrophage polarization via AMPK/mTORC1 pathway switching glycolytic reprogramming

Anti-arthritis effect of berberine associated with regulating energy metabolism of macrophages through AMPK/ HIF-1α pathway

Berberine modulates the immunometabolism and differentiation of CD4 + T cells alleviating experimental arthritis by suppression of M1-exo-miR155

Berberine Inhibits the Interleukin-1 Beta-Induced Inflammatory Response Via MAPK Downregulation in Rat Articular Chondrocytes.

The glycolysis inhibitor 2-deoxyglucose ameliorates adjuvant-induced arthritis by regulating macrophage polarization in an AMPK-dependent manner

Kidney targeting and modulating macrophage polarization through AMPK signaling: Therapeutic mechanism of berberine in uric acid nephropathy

Metabolic reprogramming of proinflammatory macrophages by target delivered roburic acid effectively ameliorates rheumatoid arthritis symptoms

Berberis lycium fruit extract and its phytoconstituents berberine and rutin mitigate collagen-CFA-induced arthritis (CIA) via improving GSK3β/STAT/Akt/MAPKs/NF-κB signaling axis mediated oxi-inflammation and joint articular damage in murine model

Berberine improved experimental chronic colitis by regulating interferon-γ- and IL-17A-producing lamina propria CD4+ T cells through AMPK activation

THU0078 Berberine ameliorates bone erosions in collagen-induced arthritis rat models via suppressing the expression of il-17a

The Crosstalk Between Nrf2 and AMPK Signal Pathways is Important for the Anti-Inflammatory Effect of Berberine in LPS-stimulated Macrophages and Endotoxin-Shocked Mice.

Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes

Protective effects of berberine in an experimental rat osteoarthritis model.

Acetylation of p65 Lys310 by p300 in macrophages mediates anti-inflammatory property of berberine

Bergenin, Acting as an Agonist of PPARγ, Ameliorates Experimental Colitis in Mice through Improving Expression of SIRT1, and Therefore Inhibiting NF-κB-Mediated Macrophage Activation

BBR affects macrophage polarization via inhibition of NF‐κB pathway to protect against T2DM‐associated periodontitis

Berberine Inhibits Palmitate-Induced NLRP3 Inflammasome Activation by Triggering Autophagy in Macrophages: A New Mechanism Linking Berberine to Insulin Resistance Improvement.

GRK2 Mediated Abnormal Transduction of PGE2-EP4-cAMP-CREB Signaling Induces the Imbalance of Macrophages Polarization in Collagen-Induced Arthritis Mice

β-Sitosterol modulates macrophage polarization and attenuates rheumatoid inflammation in mice

Synergistic rheumatoid arthritis therapy by interrupting the detrimental feedback loop to orchestrate hypoxia M1 macrophage polarization using an enzyme-catalyzed nanoplatform

Berberine Induces Dendritic Cell Apoptosis and Has Therapeutic Potential for Rheumatoid Arthritis